Vanguard Group’s BioCardia BCDA Stock Holding History

Vanguard Group’s Portfolio BCDA Stock Details BCDA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$169K	Buy	135,561 +39,063	+40%	+$53.1K	﹤0.01%	4127
2025 Q3	$124K	Buy	96,498 +83,614	+649%	+$163K	﹤0.01%	4198
2025 Q2	$25.1K	Hold	12,884	–	–	﹤0.01%	4238
2025 Q1	$32.7K	Hold	12,884	–	–	﹤0.01%	4220
2024 Q4	$28.1K	Hold	12,884	–	–	﹤0.01%	4243
2024 Q3	$40.2K	Hold	12,884	–	–	﹤0.01%	4256
2024 Q2	$38.3K	Sell	12,884 -30,500	-70%	-$153K	﹤0.01%	4306
2024 Q1	$265K	Hold	43,384	–	–	﹤0.01%	4131
2023 Q4	$432K	Hold	43,384	–	–	﹤0.01%	4085
2023 Q3	$280K	Hold	43,384	–	–	﹤0.01%	4196
2023 Q2	$1.74M	Hold	43,384	–	–	﹤0.01%	3710
2023 Q1	$1.27M	Hold	43,384	–	–	﹤0.01%	3845
2022 Q4	$1.36M	Buy	43,384 +16	+0%	+$455	﹤0.01%	3806
2022 Q3	$1.26M	Hold	43,368	–	–	﹤0.01%	3928
2022 Q2	$943K	Hold	43,368	–	–	﹤0.01%	4107
2022 Q1	$1.35M	Buy	43,368 +15,903	+58%	+$472K	﹤0.01%	4118
2021 Q4	$799K	Hold	27,465	–	–	﹤0.01%	4324
2021 Q3	$1.29M	Hold	27,465	–	–	﹤0.01%	4187
2021 Q2	$1.64M	Buy	27,465 +11,093	+68%	+$674K	﹤0.01%	4027
2021 Q1	$1.06M	Buy	16,372 +9,992	+157%	+$624K	﹤0.01%	3994
2020 Q4	$331K	Buy	+6,380	New	+$255K	﹤0.01%	4027

Other funds holding BCDA

CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Vanguard Group's BCDA Position: Q4 2025 in Review

Vanguard Group increased its BioCardia (BCDA) stake by 40% in Q4 2025, buying an estimated $53.1K and bringing the position to 135,561 shares worth $169K. The position accounts for ﹤0.01% of the portfolio, ranked #4127.

Vanguard Group first reported a position in BCDA in Q4 2020 and has held it in 21 quarters since. The position peaked at $1.74M in Q2 2023. 20 funds tracked by Wall St. Rank hold BCDA as of Q4 2025.

Vanguard Group held 135,561 shares of BioCardia worth $169K as of Q4 2025.
Vanguard Group bought 39,063 BioCardia shares in Q4 2025, an estimated $53.1K.
BioCardia made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #4127 holding.
Vanguard Group first reported a position in BioCardia in Q4 2020 and has held it in 21 quarters since.
Vanguard Group's BioCardia position peaked at $1.74M in Q2 2023.
20 funds tracked by Wall St. Rank held BioCardia as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.